Pharsight

Drugs that contain Ivosidenib

1. Tibsovo patents expiration

TIBSOVO Litigations
Can you believe TIBSOVO received compensation for the extended wait time during the regulatory approval process?
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9850277 SERVIER Therapeutically active compositions and their methods of use
Jan, 2033

(8 years from now)

US9474779 SERVIER Therapeutically active compositions and their methods of use
Aug, 2033

(9 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10610125 SERVIER Methods and compositions for cell-proliferation-related disorders
Jun, 2030

(6 years from now)

US11667673 SERVIER Therapeutically active compounds and their methods of use
Jan, 2033

(8 years from now)

US10717764 SERVIER Therapeutically active compounds and their methods of use
Jan, 2033

(8 years from now)

US10799490 SERVIER Pharmaceutical compositions of therapeutically active compounds
Mar, 2035

(11 years from now)

US10449184 SERVIER Pharmaceutical compositions of therapeutically active compounds
Mar, 2035

(11 years from now)

US9968595 SERVIER Pharmaceutical compositions of therapeutically active compounds
Mar, 2035

(11 years from now)

US10653710 SERVIER Combination therapy for treating malignancies
Oct, 2036

(12 years from now)

US10980788 SERVIER Therapy for treating malignancies
Jun, 2039

(15 years from now)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity (ODE) Oct 24, 2030
New Indication (I) May 25, 2025

Market Authorisation Date: 20 July, 2018

Treatment: A method of treating a cancer characterized by an idh1 mutation where the cancer is relapsed or refractory acute myeloid leukemia (aml) and where the mutant idh1 has the ability to convert alpha-ketog...

Dosage: TABLET;ORAL

How can I launch a generic of TIBSOVO before it's drug patent expiration?
More Information on Dosage

TIBSOVO family patents

Family Patents